Filana Therapeutics (SAVA) Q3 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q3 2024
-0.88
-0.54
-0.21
0.13

Details

Expected EPS
-0.88
Actual EPS
-0.58
Surprise EPS
0.3
Surprise Percent
+34.09%

Description

⁨Filana Therapeutics⁩ (⁦SAVA⁩) has reported earnings of ⁦-0.58⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts